Inventor · disambiguated record
Jonathan Boudreault
Also filed as: BOUDREAULT JONATHAN
4 granted patents·2 pending applications·3 citations·filing 2018–2023
65Inventor score
Top patents by PatentIndex Score
6 records- 0189US11739096B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo [1,5-A]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2022·Granted Aug 29, 2023·1 cites·2 claims
- 0281US11230546B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2018·Granted Jan 25, 2022·2 cites·20 claims
- 0379US12486276B25-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·6 claims
- 0470US2022235055A15-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo [1,5-a]pyrimidine derivatives and related compounds as trk kinase inhibitors for treating cancerPYRAMID BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0559US11208387B2Macrocyclic broad spectrum antibioticsGENENTECH INC·Filed 2020·Granted Dec 28, 2021·0 cites·6 claims
- 0659US2022135528A1Macrocyclic broad spectrum antibioticsGENENTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonathan Boudreault files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →